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Malnutrition increases morbidity and mortality and affects physical growth and development,
some of these effects resulting from specific micronutrient deficiencies. While public health
efforts must be targeted to improve dietary intakes in children through breast feeding and
appropriate complementary feeding, there is a need for additional measures to increase the
intake of certain micronutrients. Food-based approaches are regarded as the long-term strategy
for improving nutrition, but for certain micronutrients, supplementation, be it to the general
population or to high risk groups or as an adjunct to treatment must also be considered. Our
understanding of the prevalence and consequences of iron, vitamin A and iodine deficiency in
children and pregnant women has advanced considerably while there is still a need to generate
more knowledge pertaining to many other micronutrients, including zinc, selenium and many of
the B-vitamins. For iron and vitamin A, the challenge is to improve the delivery to target
populations. For disease prevention and growth promotion, the need to deliver safe but effective
amounts of micronutrients such as zinc to children and women of fertile age can be determined
only after data on deficiency prevalence becomes available and the studies on mortality
reduction following supplementation are completed. Individual or multiple micronutrients
must be used as an adjunct to treatment of common infectious diseases and malnutrition only
if the gains are substantial and the safety window sufficiently wide. The available data for zinc
are promising with regard to the prevention of diarrhea and pneumonia. It should be emphasized
that there must be no displacement of important treatment such as ORS in acute diarrhea by
adjunct therapy such as zinc. Credible policy making requires description of not only the clinical
effects but also the underlying biological mechanisms. As findings of experimental studies are
not always feasible to extrapolate to humans, the biology of deficiency as well as excess of
micronutrients in humans must continue to be investigated with vigour.
Micronutrients: Childhood infections: Diarrhoea: Acute respiratory infections: Child
development
Malnutrition increases morbidity and mortality and affects
physical growth and development. It is becoming increas-
ingly clear that some of these effects are the result of
specific nutrient deficiencies. While public health efforts
must be targeted to improve dietary intakes in children
through breast feeding and appropriate complementary
feeding, there is scope and need for additional measures to
increase intake of specific nutrients, when their deficiency
is shown to cause unacceptable adverse effects in a large
segment of the population (WHO, 1998a).
Countries are able and willing to launch interventions
only if they perceive the disease burden to be large (ACC/
SCN, 2000a). Systematically collected prevalence data in
populations, using reliable tools, that closely correlate with
functional effects is an essential first step. Obtaining such
data is not always an easy task for several reasons.
Micronutrient deficiencies, at a functionally important level
may not result in a readily identifiable clinical condition.
As an example, for each case of anaemia there are at least
two cases of iron deficiency. Except in rare hereditary
disorders, clinical diagnosis of the commonly occurring
zinc deficiency is not feasible. Moreover, there may be
causes other than low intakes, such as malaria and
hookworm infection, that increase the severity and/or
consequences of the deficiency.
Simple serum or plasma level assessment is what is usually
feasible as a biochemical indicator in population-based
assessment of micronutriture. For many micronutrients,
these levels are significantly affected by commonly
occurring acute infections, although recent studies indicate
that at least for zinc, this may be more of a concern when
assessing individuals than populations (Brown, 1998). Cut-
off values for deficiency are often arbitrary, vary from
study to study and may accordingly, when applied to
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observational studies, increase or reduce the magnitude of
association between deficiency and impaired function.
Substantial differences from laboratory to laboratory is
another problem. Age, sex, and pregnancy are other factors
that influence micronutrient status. Developing practical
and reliable measures of micronutrient deficiency is for
these reasons a continuing and important challenge.
Iodine, iron and vitamin deficiencies are major public
health problems (WHO, 1998a). The prevalence of and
disease burden associated with deficiency of several other
micronutrients, including zinc, B vitamins, calcium and
selenium, are still not well documented (FAO, 1988; Allen
et al. 1995; McCullough et al. 1990). Measuring the
prevalence of multiple micronutrient deficiency is also
important. Micronutrient deficiencies often coexist and
there are important nutrient interactions, not only at the site
of absorption, such as for zinc and iron, but also in
functional terms.
Furthermore, iodine and selenium are involved in the
normal function of the thyroid gland and inadequate intake
of both micronutrients causes hypothyroid cretinism.
Research in Tibet suggests that this co-deficiency causes
Kashin-Beck’s disease, a condition associated with short
stature caused by multifocal necrosis of the growth plates in
the long bones and osteoarthritis (Moreno-Reyes et al.
1998).
Our understanding of the consequences of iron, vitamin
A and iodine deficiency in children has advanced
considerably (ACC/SCN, 2000a; WHO, 2000). Iron
deficiency anaemia affects physical growth. Whether iron
deficiency per se significantly increases the incidence and/
or the severity of infections is not well established and
there is even concern that administration of iron during
latent or uncontrolled infections may be unsafe (Weinberg,
1996), as was shown during bacterial infections in neonates
(Farmer & Becroft, 1976; Barry & Reeve, 1977; Becroft
et al. 1977). It was recently concluded that reasonable oral
doses do not cause increase in malaria (INACG, 1999;
Menendez et al. 1997). Parenteral administration of iron
however, increases malarial morbidity in non-immune
individuals and possibly morbidity of other infections as
well (Oppenheimer et al. 1986a; Oppenheimer et al.
1986b). The dominant adverse effect of iron deficiency is
on cognition in children (Edgerton et al. 1979; Fairweather-
Tait, 1992; Walter, 1993; Gillespie, 1997; Gillespie, 1998).
There is clinical evidence for reduced immuno-competence
in individuals with iron deficiency but it is less clear
whether this leads to increased severity of infection. A
recent analysis of the economic consequences of iron
deficiency has estimated the median value of productivity
losses due to iron deficiency to be about EURO 4 per capita
or 0–9 % of the Gross National Product for a range of
developing countries (Edgerton et al. 1979).
Vitamin A is an essential micronutrient for the normal
function of the visual system, for growth, development, and
maintenance of epithelial cellular integrity as well as for
immune function and reproduction (Bhan & Bhandari,
1998; WHO, UNICEF & IVACG, 1997; WHO, 1998b;
WHO & UNICEF, 1998). Effects on epithelial barriers and
on the immune system occur even with subclinical
deficiency, leading to increased severity of some infections
and an increased risk of death among children. Vitamin A
supplementation was reported to reduce mortality by 23 %
in children 6 months to 5 years of age in vitamin A
deficient areas (Beaton et al. 1993). This indicates that low
body vitamin A, even without overt clinical manifestations,
has important health consequences, particularly on the
outcome of important infections (Beaton et al. 1993).
Vitamin A supplementation at appropriate levels has been
found to improve vitamin A as well as iron status. A
vitamin A sugar fortification programme in Guatemala
resulted in improved iron status of the population (Mejia &
Arroyave, 1982; Mejia & Chew, 1988; Suharno & Muhilal,
1996; Gillespie, 1997).
Iodine is required for the synthesis of thyroid hormones
and plays a key role in cell replication. Gestational iodine
deficiency leads to abortions, still births, congenital
anomalies, low birth weight, cretinism, psychomotor
defects and increased neonatal mortality. Goitre, hypothy-
roidism, impaired mental function, retarded mental and
physical development and diminished school performance
is seen during childhood and adolescence. Severe iodine
deficiency causes substantial linear growth retardation
which can be partly reversed by iodine supplementation
(Delange, 1985; WHO, 1998a; Delange, 1999; WHO,
UNICEF & ICCIDD, 1999). In adults, complications of
goitre such as hypothyroidism and impaired mental
function persist.
Zinc deficiency has long been suspected to be prevalent
in children in developing countries where diets are low in
animal products and high in phytates. Diarrhea exacerbates
zinc deficiency due to intestinal loss. Observational studies
are of limited value in identifying functional effects of its
deficiency since reliable indicators of zinc status that are
suitable for field studies are not available and the possible
confounding effect of coexisting nutrient deficiencies is
difficult to eliminate. Several recent studies in preschool
children of developing countries have shown that zinc
supplementation does not only result in enhanced linear
growth, but also leads to substantial reductions in the
incidence and severity of acute and persistent diarrhea, and
possibly of lower respiratory tract infections (Child Health
Research Project, 1997; Black, 1998a; Sazawal et al. 1998;
Brown et al. 1998; Zinc Investigators’ Collaborative
Group, 1999; Roy et al. 1999). In this issue, Black &
Sazawal have reviewed available zinc trials in children.
The fact that the effects of zinc supplementation in
developing country children seems to be more pronounced
in severe diarrheal and acute respiratory illnesses raises the
possibility of mortality reduction if the zinc intake in
deficient populations can be increased. Clinical trials
addressing this issue are underway in Tanzania, Nepal
and India.
With regard to health effects of zinc deficiency, there
are several unresolved issues. Are the effects of zinc
supplementation on morbidity only the result of correction
of deficiency, and as such restricted to zinc deficient
children, or does zinc also have a pharmacological effect?
Can anthropometry be used to identify children likely to be
zinc deficient? The effect of zinc supplementation in
children below 6 months of age, particularly in those born
with low birth weight, is of particular interest as they carry
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a high risk of severe systemic infections and death. Early
findings from an Indian trial showed a 67 % mortality
reduction in small for gestational age infants 1–8 months
old who were supplemented daily for the first year of life
(Black, 1999, personal communication). Routine zinc
supplementation improves physical activity but the effects
on cognition are still uncertain (Black, 1998b).
Selenium deficiency has been identified in China, Tibet,
New Zealand and the Russian Federation. It can result in
thyroid injury and decreased thyroid hormone production.
Moreover, it may cause Keshan’s disease, which is an
endemic cardiomyopathy mainly affecting children and
women of childbearing age. Epidemiological evidence
linking selenium deficiency to Keshan’s disease (Ge &
Yang, 1993) led to large scale selenium supplementation
programmes which together with changes in the diet has
virtually eliminated the disease from China. However,
more work is required to define acceptable norms for
selenium intake, the prevalence of its deficiency and its
public health significance.
Acute infections such as diarrhea and pneumonia, last
longer and are more severe in the malnourished host. There
is now evidence that therapeutic use of specific nutrients
early in some acute illnesses may reduce episode severity
and duration and even case fatality. This has been
established for all these outcomes with vitamin A in
measles and for episode severity and duration with zinc in
acute and persistent diarrhea (Sazawal et al. 1995; WHO,
UNICEF & IVACG, 1997; WHO, UNICEF & ICCID,
1999; Penny et al. 1999). On the other hand, overzealous
administration of large doses of zinc to severely mal-
nourished children was shown to actually increase
mortality, highlighting the need for attention to safety
issues (Faruque et al. 1998). In this issue, Mahalanabis &
Bhan discuss the policy implications of therapeutic use of
single or multiple micronutrients during acute illness in
children. Overall, individual micronutrients must be used
only if the gains are substantial and the safety window
between therapeutic and toxic dose is sufficiently wide.
The need to deliver safe but effective amounts of zinc to
children in developing countries can be determined only
after data on deficiency becomes available and the studies
on mortality reduction following supplementation are
completed. In countries where iron–folic acid supplemen-
tation is recommended up to 3 years of age, such as in
India, the possibility of adding zinc to this formulation is an
option if constituted in a way that does not significantly
affect the bioavailability of either of the three micro-
nutrients nor reduce the compliance in the target group.
This may be feasible if the relative dosage and salts are
compatible and appropriate. Food fortification and plant
breeding are clearly more practical options for increasing
the intake of micronutrients for which body stores are not
built, as in the case of zinc.
In the Goa conference, data presented from Pune, India,
indicated that, among adults, vitamin B12 deficiency may
be more prevalent than folate deficiency. This observation
is supported by recent findings among pregnant Nepali
women and among children in Delhi (Bondevik et al. 2000;
Gomber et al. 1998). In the current issue, Refsum points
out that folate supplementation to individuals with latent or
overt vitamin B12 deficiency may, in fact, worsen the
metabolic consequences of such deficiency. Moreover,
Sandstrøm points out that the intake of aqueous solutions of
iron, i.e. as in iron supplements, may impinge on zinc
uptake. Accordingly, studies to evaluate the clinical and
metabolic consequences of iron–folate supplementation
and, over a longer time perspective, to examine the
relevance and feasibility of broadening the supplement to
include other micronutrients, such as vitamin B12 and zinc,
should be considered.
However, at this point there is insufficient evidence to
support the use of multiple micronutrient formulations in
infants and young children and, indeed, because of
interactions or of opposing effects on the immune or
other systems, the benefits as compared to single or a
limited number of micronutrients may be reduced. Multiple
micronutrients are currently recommended in severely
malnourished children or in those who, for some reason,
are unable to achieve adequate dietary intakes for extended
periods of time, such as children with chronic gastro-
intestinal or other disorders (WHO & UNICEF, 2000).
Substantial progress has been made in recent years
towards the elimination of iodine deficiency and in
reducing the prevalence of vitamin A deficiency (WHO,
UNICEF & IVACG, 1997; UNICEF, MI, WHO, CIDA &
USAID, 1998; ICCIDD, 1998; WHO, UNICEF & ICCIDD,
1999). On the other hand, the effectiveness of the
programmes for the control of iron deficiency has been
poor. Despite available tools, iron supplementation pro-
grammes have been limited by insufficient supplies,
inadequate commitment of health care providers and their
supervisors, and poor compliance in the target populations
who often are unaware of mild to moderate anaemia and its
consequences. Recent analyses show that neither daily nor
intermittent supplementation is likely to prove effective in
developing countries and other strategies are required for
improving utilizable iron intakes (Beaton & McGable,
1999). Apart from supplementation, progress has been
made in iron fortification of staple and complementary
foods and this approach needs to be pursued with vigour.
Recent reviews suggest that the concern regarding iron
overload in iron deficient populations may be exaggerated,
although the safety issues must of course be continuously
evaluated.
Plant breeding to increase the content and bioavailability
of iron and other micronutrients holds great promise
(Graham & Welch, 1996; Ruel & Bouis, 1998). The
goals are to increase the concentration of micronutrients
and/or the efficiency of their utilization in the crop,
decrease the concentration of absorption inhibitors such
as phytates and increase the amount of promoter com-
pounds (for iron and zinc in particular) such as sulphur
containing amino acids (ACC/SCN, 2000b). The technol-
ogies span from the selection of naturally occurring genetic
variants with relatively high metabolic efficiency in the use
of elements such as zinc, genetic modification of plants,
and the creation of new foods using biotechnology to
micronutrient fortification of fertilizers. Although extensive
use of phosphorous-containing fertilizers is necessary for
high yields of cereals it can also induce zinc deficiency in
crops, especially in many of the new high yielding
S201Micronutrients in children
varieties, and may also increase the phytate content of the
grain used for human consumption. Adding zinc sulphate to
zinc deficient soils can increase crop yields substantially
and also, to some extent, increase the zinc content of the
edible portions of the plants. This is an example of an
agricultural intervention where producers benefit while
consumers may experience a substantial health benefit.
However, there are many challenges. Will farmers be
interested in crop cultivars that have higher micronutrient
concentrations or utilization efficiency but little or no yield
advantage? Will the target population have access to or
accept these new foods? Moreover, strategies that increase
the concentrations of some micronutrients may have a
negative impact on the bioavailability of others, such
antagonism may be observed between copper, zinc and
manganese.
There are still problems related to the delivery of vitamin
A (WHO, UNICEF & IVACG, 1997; HKI, 1997; WHO,
1998b; WHO & UNICEF, 1998; UNICEF, MI, WHO,
CIDA & USAID, 1998; WHO, UNICEF, MI, World Bank,
CIDA & USAID, 1997). The intention is to deliver at least
two doses per year to deficient child populations. Measles
immunization is often the only effective opportunity to
deliver vitamin A. Addition of vitamin A to national
immunization days has been proposed and even adopted in
some places (WHO, UNICEF, MI, World Bank, CIDA &
USAID, 1997; WHO & UNICEF, 1998; WHO, 1998b).
One important concern is that this may tend to destabilise
the delivery of vitamin A through routine health care and
nutritional services. The sustainability and safety of such an
approach must be carefully evaluated.
There is wide agreement in support of food-based
approaches as the long-term strategy for improving
nutrition in general and micronutriture in particular
(Muhilal et al. 1988). Fortification of maize and sugar
with vitamin A are currently being explored in some
countries. Other innovations include egg promotion in
Indonesia and genetic modification of staple foods to
enhance vitamin A bioavailability, as has been attempted
with iron.
Credible policy making requires a detailed description of
not only the clinical effects but also the underlying
biological mechanisms. As findings of experimental studies
are not always feasible to extrapolate to humans, the
biology of deficiency as well as excess of micronutrient in
humans must continue to be investigated with vigour using
a multidisciplinary approach.
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